Literature DB >> 10536901

Angelman syndrome: a review of clinical and genetic aspects.

L A Laan1, A v Haeringen, O F Brouwer.   

Abstract

This paper reviews Angelman syndrome (AS) with regard to the clinical features in childhood and adulthood, epileptic seizures and EEG findings, neuroimaging studies and the present knowledge on the genetic mechanisms underlying this syndrome. Different clinical phenotypes and genotypes of AS are described, including chromosome 15q11-13 deletion, uniparental disomy, methylation imprinting abnormalities and mutations in the UBE3A gene.

Entities:  

Mesh:

Year:  1999        PMID: 10536901     DOI: 10.1016/s0303-8467(99)00030-x

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  21 in total

1.  MECP2 mutation in non-fatal, non-progressive encephalopathy in a male.

Authors:  B Imessaoudene; J P Bonnefont; G Royer; V Cormier-Daire; S Lyonnet; G Lyon; A Munnich; J Amiel
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

2.  Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

Authors:  Richard M Gustin; Terry Jo Bichell; Michael Bubser; Jennifer Daily; Irina Filonova; Davit Mrelashvili; Ariel Y Deutch; Roger J Colbran; Edwin J Weeber; Kevin F Haas
Journal:  Neurobiol Dis       Date:  2010-04-25       Impact factor: 5.996

3.  Ube3a imprinting impairs circadian robustness in Angelman syndrome models.

Authors:  Shu-qun Shi; Terry Jo Bichell; Rebecca A Ihrie; Carl Hirschie Johnson
Journal:  Curr Biol       Date:  2015-02-05       Impact factor: 10.834

4.  Revisiting epilepsy and the electroencephalogram patterns in Angelman syndrome.

Authors:  Marcio Leyser; Patricia Sola Penna; Alexandre Cardozo de Almeida; Marcio Moacyr Vasconcelos; Osvaldo J M Nascimento
Journal:  Neurol Sci       Date:  2014-01-07       Impact factor: 3.307

5.  Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome.

Authors:  Edwin J Weeber; Yong-Hui Jiang; Ype Elgersma; Andrew W Varga; Yarimar Carrasquillo; Sarah E Brown; Jill M Christian; Banefsheh Mirnikjoo; Alcino Silva; Arthur L Beaudet; J David Sweatt
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

6.  Asystole during outbursts of laughing in a child with Angelman syndrome.

Authors:  W Y Vanagt; C F Pulles-Heintzberger; K Vernooy; R N Cornelussen; T Delhaas
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

7.  Distinct phenotypes distinguish the molecular classes of Angelman syndrome.

Authors:  A C Lossie; M M Whitney; D Amidon; H J Dong; P Chen; D Theriaque; A Hutson; R D Nicholls; R T Zori; C A Williams; D J Driscoll
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

Review 8.  Vagal nerve stimulation for medically refractory epilepsy in Angelman syndrome: a series of three cases.

Authors:  Krystal L Tomei; Christine Y Mau; Michael Ghali; Jayoung Pak; Ira M Goldstein
Journal:  Childs Nerv Syst       Date:  2018-01-19       Impact factor: 1.475

Review 9.  Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.

Authors:  Renzo Guerrini; Romeo Carrozzo; Roberta Rinaldi; Paolo Bonanni
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 10.  Epilepsy in Prader-Willi syndrome: clinical, diagnostic and treatment aspects.

Authors:  Alberto Verrotti; Claudia Soldani; Daniela Laino; Renato d'Alonzo; Salvatore Grosso
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.